Comparison of Advanced Hemodynamic Monitoring With Standard Monitoring During Propofol Sedation in ERCP Procedures: A Prospective Observational Study

What this Trial Is About

This research aims to compare advanced hemodynamic monitoring with standard monitoring during propofol sedation for ERCP procedures, focusing on whether advanced monitoring better detects hemodynamic events needing intervention. ERCP is used mainly for therapeutic treatment of biliary and pancreatic duct disorders, especially in elderly patients who often face hemodynamic challenges during sedation due to comorbidities. Maintaining adequate organ blood flow and oxygen is crucial, and standard monitoring may miss some important hemodynamic changes. The study has two groups: one group receives standard monitoring including non-invasive blood pressure, ECG, pulse oximetry, and BIS without arterial cannulation. The other group receives advanced monitoring using the MostCare system via radial arterial cannulation, capturing detailed parameters like cardiac output, stroke volume, systemic vascular resistance, and cardiac power output. Both groups undergo ERCP under propofol sedation, with advanced monitoring aimed at providing more detailed data to guide interventions. Participants will be adults aged 18 or older with certain physical health status undergoing ERCP while breathing on their own. They will be monitored from the start of sedation until the end of the procedure for hemodynamic events requiring clinical intervention. The study will record the number of such events and compare findings between the two monitoring methods. Consent and continuous monitoring ensure participant safety throughout the procedure.

Advanced vs Standard Hemodynamic Monitoring During Propofol Sedation for ERCP: A Prospective Study